LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
94808-3
|
COVID-19+Intubation+Consultation note
|
Find
|
Pt
|
{Setting}
|
Doc
|
Resident
|
DOC.ONTOLOGY
| 2 |
Resident COVID-19 Intubation Consultation note
|
Res COVID-19 Intub+Consult
| null |
ACTIVE
|
2.68
|
2.7
|
94809-1
|
COVID-19+Intubation+Progress note
|
Find
|
Pt
|
{Setting}
|
Doc
|
{Role}
|
DOC.ONTOLOGY
| 2 |
COVID-19 Intubation Progress note
|
COVID-19 Intub+Progress
| null |
ACTIVE
|
2.68
|
2.7
|
94810-9
|
COVID-19+Intubation+Procedure note
|
Find
|
Pt
|
{Setting}
|
Doc
|
{Role}
|
DOC.ONTOLOGY
| 2 |
COVID-19 Intubation Procedure note
|
COVID-19 Intub Proced
| null |
ACTIVE
|
2.68
|
2.7
|
94811-7
|
COVID-19+Intubation+Evaluation note
|
Find
|
Pt
|
{Setting}
|
Doc
|
{Role}
|
DOC.ONTOLOGY
| 2 |
COVID-19 Intubation Evaluation note
|
COVID-19 Intub Eval note
| null |
ACTIVE
|
2.68
|
2.7
|
94812-5
|
COVID-19+Intubation+Cardiopulmonary resuscitation note
|
Find
|
Pt
|
{Setting}
|
Doc
|
{Role}
|
DOC.ONTOLOGY
| 2 |
COVID-19 Intubation and Cardiopulmonary resuscitation note
|
COVID-19 Intub+CPR
| null |
ACTIVE
|
2.68
|
2.7
|
9481-3
|
pH
|
LsCnc
|
Pt
|
Water
|
Qn
| null |
CHEM
| 1 |
pH of Water
|
pH Wat
| null |
ACTIVE
|
1.0i
|
2.42
|
94813-3
|
COVID-19+Intubation+Conference note
|
Find
|
Pt
|
{Setting}
|
Doc
|
Team
|
DOC.ONTOLOGY
| 2 |
Team COVID-19 Intubation Conference note
|
Team COVID-19 Intub Conference
| null |
ACTIVE
|
2.68
|
2.7
|
94814-1
|
COVID-19+Consultation note
|
Find
|
Pt
|
{Setting}
|
Doc
|
Critical Care Medicine
|
DOC.ONTOLOGY
| 2 |
Critical care medicine COVID-19 Consultation note
|
CCM COVID-19 Consult note
| null |
ACTIVE
|
2.68
|
2.7
|
94815-8
|
CV2 Ab.IgG
|
Titr
|
Pt
|
Ser
|
Qn
|
IF
|
SERO
| 1 |
CV2 IgG Ab [Titer] in Serum by Immunofluorescence
|
CV2 IgG Titr Ser IF
| null |
ACTIVE
|
2.68
|
2.68
|
94816-6
|
Voltage-gated potassium channel Ab
|
SCnc
|
Pt
|
Ser
|
Qn
|
IA
|
SERO
| 1 |
Voltage-gated potassium channel Ab [Moles/volume] in Serum by Immunoassay
|
VGKC Ab Ser IA-sCnc
| null |
ACTIVE
|
2.68
|
2.68
|
94817-4
|
Striated muscle Ab
|
Titr
|
Pt
|
Ser
|
Qn
|
IA
|
SERO
| 1 |
Striated muscle Ab [Titer] in Serum by Immunoassay
|
Stria Mus Ab Titr Ser IA
| null |
ACTIVE
|
2.68
|
2.68
|
94818-2
|
Paraneoplastic Ab panel
|
-
|
Pt
|
CSF
|
-
|
IF
|
PANEL.SERO
| 1 |
Paraneoplastic Ab panel - Cerebral spinal fluid by Immunofluorescence
|
Paraneoplastic Ab Pnl CSF IF
| null |
ACTIVE
|
2.68
|
2.68
|
94819-0
|
SARS coronavirus 2 RNA
|
LnCnc
|
Pt
|
XXX
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) RNA [Log #/volume] (viral load) in Specimen by NAA with probe detection
|
SARS-CoV-2 RNA Spec NAA+probe-Log#
| null |
ACTIVE
|
2.68
|
2.69
|
94820-8
|
Whole mRNA transcriptome sequence analysis
|
Find
|
Pt
|
Bld/Tiss
|
Doc
|
Sequencing
|
MOLPATH
| 1 |
Whole mRNA transcriptome sequence analysis in Blood or Tissue by Sequencing
|
Whole mRNA Seq Analysis Bld/T Seq
| null |
ACTIVE
|
2.68
|
2.68
|
9482-1
|
Potassium
|
MCnc
|
Pt
|
Water
|
Qn
| null |
CHEM
| 1 |
Potassium [Mass/volume] in Water
|
Potassium Wat-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
94821-6
|
COVID-19+Intubation advance directives
|
Find
|
Pt
|
{Setting}
|
Doc
|
{Role}
|
DOC.ONTOLOGY
| 2 |
COVID-19 Intubation advance directives
|
COVID-19 Intubation Adv Dir
| null |
ACTIVE
|
2.68
|
2.7
|
94822-4
|
SARS coronavirus 2 RNA
|
PrThr
|
Pt
|
Saliva
|
Ord
|
Sequencing
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by Sequencing
|
SARS-CoV-2 RNA Sal Ql Seq
| null |
ACTIVE
|
2.68
|
2.69
|
94823-2
|
Cytomegalovirus DNA
|
LnCnc
|
Pt
|
Amnio fld
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Cytomegalovirus DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection
|
CMV DNA Amn NAA+probe-Log#
| null |
ACTIVE
|
2.68
|
2.68
|
94824-0
|
Parvovirus B19 DNA
|
ACnc
|
Pt
|
Amnio fld
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Parvovirus B19 DNA [Units/volume] (viral load) in Amniotic fluid by NAA with probe detection
|
B19V DNA Amn NAA+probe-aCnc
| null |
ACTIVE
|
2.68
|
2.68
|
94825-7
|
Parvovirus B19 DNA
|
LaCnc
|
Pt
|
Amnio fld
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Parvovirus B19 DNA [log units/volume] (viral load) in Amniotic fluid by NAA with probe detection
|
B19V DNA Amn NAA+probe-Log IU
| null |
ACTIVE
|
2.68
|
2.68
|
94826-5
|
Parvovirus B19 DNA
|
LnCnc
|
Pt
|
Amnio fld
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Parvovirus B19 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection
|
B19V DNA Amn NAA+probe-Log#
| null |
ACTIVE
|
2.68
|
2.68
|
94827-3
|
Epstein Barr virus DNA
|
PrThr
|
Pt
|
Amnio fld
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
Epstein Barr virus DNA [Presence] in Amniotic fluid by NAA with probe detection
|
EBV DNA Amn Ql NAA+probe
| null |
ACTIVE
|
2.68
|
2.68
|
94828-1
|
Epstein Barr virus DNA
|
ACnc
|
Pt
|
Amnio fld
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Epstein Barr virus DNA [Units/volume] (viral load) in Amniotic fluid by NAA with probe detection
|
EBV DNA Amn NAA+probe-aCnc
| null |
ACTIVE
|
2.68
|
2.68
|
94829-9
|
Epstein Barr virus DNA
|
LaCnc
|
Pt
|
Amnio fld
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Epstein Barr virus DNA [log units/volume] (viral load) in Amniotic fluid by NAA with probe detection
|
EBV DNA Amn NAA+probe-Log IU
| null |
ACTIVE
|
2.68
|
2.68
|
94830-7
|
Epstein Barr virus DNA
|
LnCnc
|
Pt
|
Amnio fld
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Epstein Barr virus DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection
|
EBV DNA Amn NAA+probe-Log#
| null |
ACTIVE
|
2.68
|
2.68
|
94831-5
|
Varicella zoster virus DNA
|
ACnc
|
Pt
|
Amnio fld
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Varicella zoster virus DNA [Units/volume] (viral load) in Amniotic fluid by NAA with probe detection
|
VZV DNA Amn NAA+probe-aCnc
| null |
ACTIVE
|
2.68
|
2.68
|
94832-3
|
Varicella zoster virus DNA
|
LaCnc
|
Pt
|
Amnio fld
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Varicella zoster virus DNA [log units/volume] (viral load) in Amniotic fluid by NAA with probe detection
|
VZV DNA Amn NAA+probe-Log IU
| null |
ACTIVE
|
2.68
|
2.68
|
94833-1
|
Varicella zoster virus DNA
|
LnCnc
|
Pt
|
Amnio fld
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Varicella zoster virus DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection
|
VZV DNA Amn NAA+probe-Log#
| null |
ACTIVE
|
2.68
|
2.68
|
94834-9
|
Herpes simplex virus 1+2 DNA
|
LnCnc
|
Pt
|
Amnio fld
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Herpes simplex virus 1+2 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection
|
HSV1+2 DNA Amn NAA+probe-Log#
| null |
ACTIVE
|
2.68
|
2.68
|
94835-6
|
Herpes simplex virus 1 DNA
|
LnCnc
|
Pt
|
Amnio fld
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Herpes simplex virus 1 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection
|
HSV1 DNA Amn NAA+probe-Log#
| null |
ACTIVE
|
2.68
|
2.68
|
94836-4
|
Herpes simplex virus 2 DNA
|
LnCnc
|
Pt
|
Amnio fld
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Herpes simplex virus 2 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection
|
HSV2 DNA Amn NAA+probe-Log#
| null |
ACTIVE
|
2.68
|
2.68
|
94837-2
|
Dengue virus 1+2+3+4 RNA
|
PrThr
|
Pt
|
Amnio fld
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
Dengue virus 1+2+3+4 RNA [Presence] in Amniotic fluid by NAA with probe detection
|
DENV1+2+3+4 RNA Amn Ql NAA+probe
| null |
ACTIVE
|
2.68
|
2.68
|
94838-0
|
Enterovirus RNA
|
PrThr
|
Pt
|
Amnio fld
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
Enterovirus RNA [Presence] in Amniotic fluid by NAA with probe detection
|
EV RNA Amn Ql NAA+probe
| null |
ACTIVE
|
2.68
|
2.68
|
9483-9
|
Selenium
|
MCnc
|
Pt
|
Water
|
Qn
| null |
DRUG/TOX
| 1 |
Selenium [Mass/volume] in Water
|
Selenium Wat-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
94839-8
|
Calcium
|
MCnc
|
Pt
|
Urine^Fetus
|
Qn
| null |
CHEM
| 1 |
Calcium [Mass/volume] in Urine from Fetus
|
Calcium Ur Fetus-mCnc
| null |
ACTIVE
|
2.68
|
2.68
|
94840-6
|
Chloride
|
SCnc
|
Pt
|
Urine^Fetus
|
Qn
| null |
CHEM
| 1 |
Chloride [Moles/volume] in Urine from Fetus
|
Chloride Ur Fetus-sCnc
| null |
ACTIVE
|
2.68
|
2.68
|
94841-4
|
Potassium
|
SCnc
|
Pt
|
Urine^Fetus
|
Qn
| null |
CHEM
| 1 |
Potassium [Moles/volume] in Urine from Fetus
|
Potassium Ur Fetus-sCnc
| null |
ACTIVE
|
2.68
|
2.68
|
94842-2
|
Sodium
|
SCnc
|
Pt
|
Urine^Fetus
|
Qn
| null |
CHEM
| 1 |
Sodium [Moles/volume] in Urine from Fetus
|
Sodium Ur Fetus-sCnc
| null |
ACTIVE
|
2.68
|
2.68
|
94843-0
|
Osmolality
|
Osmol
|
Pt
|
Urine^Fetus
|
Qn
| null |
CHEM
| 1 |
Osmolality of Urine from Fetus
|
Osmolality Ur Fetus
| null |
ACTIVE
|
2.68
|
2.68
|
94844-8
|
Creatinine
|
MCnc
|
Pt
|
Urine^Fetus
|
Qn
| null |
CHEM
| 1 |
Creatinine [Mass/volume] in Urine from Fetus
|
Creat Ur Fetus-mCnc
| null |
ACTIVE
|
2.68
|
2.68
|
94845-5
|
SARS coronavirus 2 RNA
|
PrThr
|
Pt
|
Saliva
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
|
SARS-CoV-2 RNA Sal Ql NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
94846-3
|
Specimen collection problem
|
Hx
|
Pt
|
^Patient
|
Nom
| null |
H&P.HX
| 2 |
History of Specimen collection problem
|
Hx of Spec collection problem
| null |
ACTIVE
|
2.68
|
2.68
|
9484-7
|
Silver
|
MCnc
|
Pt
|
Water
|
Qn
| null |
DRUG/TOX
| 1 |
Silver [Mass/volume] in Water
|
Silver Wat-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
94847-1
|
Reason specimen not collected
|
Find
|
Pt
|
Specimen
|
Nom
| null |
SPEC
| 1 |
Reason specimen not collected
|
Reason spec not collected
| null |
ACTIVE
|
2.68
|
2.68
|
94848-9
|
Functional assessment standardized items (FASI) - version 1.0
|
-
|
-
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
Functional assessment standardized items (FASI) - version 1.0 [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94849-7
|
FASI v1.0 - Self-care - usual performance
|
-
|
RptPeriod
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
FASI v1.0 - Self-care - usual performance during assessment period [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.69
|
94850-5
|
FASI v1.0 - Self-care - most dependent performance
|
-
|
1Mo
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
FASI v1.0 - Self-care - most dependent performance [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94851-3
|
FASI v1.0 - Mobility - usual performance
|
-
|
RptPeriod
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
FASI v1.0 - Mobility - usual performance during assessment period [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.69
|
94852-1
|
FASI v1.0 - Mobility - most dependent performance
|
-
|
1Mo
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
FASI v1.0 - Mobility - most dependent performance [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94853-9
|
West Nile virus Ab.IgG & IgM panel
|
-
|
Pt
|
CSF
|
Ord
| null |
PANEL.MICRO
| 1 |
West Nile virus IgG and IgM panel - Cerebral spinal fluid Qualitative
|
WNV IgG+IgM Pnl CSF
| null |
ACTIVE
|
2.68
|
2.68
|
9485-4
|
Sodium
|
MCnc
|
Pt
|
Water
|
Qn
| null |
CHEM
| 1 |
Sodium [Mass/volume] in Water
|
Sodium Wat-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
94854-7
|
West Nile virus Ab.IgG & IgM panel
|
-
|
Pt
|
Ser
|
Ord
| null |
PANEL.MICRO
| 1 |
West Nile virus IgG and IgM panel - Serum Qualitative
|
WNV IgG+IgM Pnl Ser
| null |
ACTIVE
|
2.68
|
2.68
|
94855-4
|
Carbamazepine hypersensitivity genotype panel
|
-
|
Pt
|
Bld/Tiss
|
-
| null |
PANEL.MOLPATH.PHARMG
| 1 |
carBAMazepine hypersensitivity genotype panel - Blood or Tissue
|
carBAMazepine hypersens geno Pnl Bld/T
| null |
ACTIVE
|
2.68
|
2.68
|
94856-2
|
Microscopic observation^2nd specimen
|
PrThr
|
Pt
|
Sputum
|
Ord
|
Acid fast stain
|
MICRO
| 1 |
Microscopic observation [Presence] in Sputum by Acid fast stain --2nd specimen
|
Acid fast Stn sp2 Spt Ql
| null |
ACTIVE
|
2.68
|
2.68
|
94857-0
|
Microscopic observation^3rd specimen
|
PrThr
|
Pt
|
Sputum
|
Ord
|
Acid fast stain
|
MICRO
| 1 |
Microscopic observation [Presence] in Sputum by Acid fast stain --3rd specimen
|
Acid fast Stn sp3 Spt Ql
| null |
ACTIVE
|
2.68
|
2.68
|
94858-8
|
Glycerol
|
SCnc
|
Pt
|
Ser
|
Qn
|
Calculated
|
CHEM
| 1 |
Glycerol [Moles/volume] in Serum by calculation
|
Glycerol Ser Calc-sCnc
| null |
ACTIVE
|
2.68
|
2.68
|
94859-6
|
Glycerol & Glycerol-corrected triglyceride panel
|
-
|
Pt
|
Ser/Plas
|
-
| null |
PANEL.CHEM
| 1 |
Glycerol and glycerol-corrected triglyceride panel - Serum or Plasma
|
Glycerol + glycerol corr TG Pnl SerPl
| null |
ACTIVE
|
2.68
|
2.68
|
94860-4
|
Transthyretin
|
Mass
|
Pt
|
Bld
|
Qn
| null |
CHEM
| 1 |
Transthyretin [Mass] in Blood
|
TTR Bld Qn
| null |
ACTIVE
|
2.68
|
2.68
|
94861-2
|
Transthyretin - transthyretin peak 2
|
MDiff
|
Pt
|
Bld
|
Qn
| null |
CHEM
| 1 |
Transthyretin - transthyretin peak 2 [Mass difference] in Blood
|
TTR - TTR 2 MDiff Bld
| null |
ACTIVE
|
2.68
|
2.68
|
9486-2
|
Sulfate
|
MCnc
|
Pt
|
Water
|
Qn
| null |
CHEM
| 1 |
Sulfate [Mass/volume] in Water
|
Sulfate Wat-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
94862-0
|
Transthyretin peak 2
|
Mass
|
Pt
|
Bld
|
Qn
| null |
CHEM
| 1 |
Transthyretin peak 2 [Mass] in Blood
|
TTR 2 Bld Qn
| null |
ACTIVE
|
2.68
|
2.68
|
94863-8
|
Transthyretin width at half peak height
|
Mass
|
Pt
|
Bld
|
Qn
| null |
CHEM
| 1 |
Transthyretin width at half peak height [Mass] in Blood
|
TTR width at half height Bld Qn
| null |
ACTIVE
|
2.68
|
2.68
|
94864-6
|
Transthyretin-associated familial amyloidosis panel
|
-
|
Pt
|
Bld
|
-
| null |
PANEL.CHEM
| 1 |
Transthyretin-associated familial amyloidosis panel - Blood
|
TTR-assoc familial amyloidosis Pnl Bld
| null |
ACTIVE
|
2.68
|
2.68
|
94865-3
|
Triglyceride^^corrected for glycerol
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
CHEM
| 1 |
Triglyceride [Mass/volume] corrected for glycerol in Serum
|
Trigl Glycer cor Ser-mCnc
| null |
ACTIVE
|
2.68
|
2.68
|
94866-1
|
7-Alpha hydroxy-4-cholesten-3-one
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
CHEM
| 1 |
7-Alpha hydroxy-4-cholesten-3-one [Mass/volume] in Serum or Plasma
|
7a-OH-4-chol-3-one SerPl-mCnc
| null |
ACTIVE
|
2.68
|
2.68
|
94867-9
|
Ganglioside GD1b Ab.IgG
|
Titr
|
Pt
|
Ser
|
Qn
|
IA
|
SERO
| 1 |
Ganglioside GD1b IgG Ab [Titer] in Serum by Immunoassay
|
GD1b Gangl IgG Titr Ser IA
| null |
ACTIVE
|
2.68
|
2.68
|
94868-7
|
Ganglioside GD1b Ab.IgG
|
PrThr
|
Pt
|
Ser
|
Ord
|
IA
|
SERO
| 1 |
Ganglioside GD1b IgG Ab [Presence] in Serum by Immunoassay
|
GD1b Gangl IgG Ser Ql IA
| null |
ACTIVE
|
2.68
|
2.68
|
94869-5
|
Ganglioside GD1b Ab.IgM
|
Titr
|
Pt
|
Ser
|
Qn
|
IA
|
SERO
| 1 |
Ganglioside GD1b IgM Ab [Titer] in Serum by Immunoassay
|
GD1b Gangl IgM Titr Ser IA
| null |
ACTIVE
|
2.68
|
2.68
|
9487-0
|
Zinc
|
MCnc
|
Pt
|
Water
|
Qn
| null |
DRUG/TOX
| 1 |
Zinc [Mass/volume] in Water
|
Zinc Wat-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
94870-3
|
Ganglioside GD1b Ab.IgM
|
PrThr
|
Pt
|
Ser
|
Ord
|
IA
|
SERO
| 1 |
Ganglioside GD1b IgM Ab [Presence] in Serum by Immunoassay
|
GD1b Gangl IgM Ser Ql IA
| null |
ACTIVE
|
2.68
|
2.68
|
94871-1
|
Aldosterone & sodium panel
|
-
|
24H
|
Urine
|
Qn
| null |
PANEL.CHEM
| 1 |
Aldosterone and sodium panel - 24 hour Urine
|
Aldosterone + Na Pnl 24h Ur
| null |
ACTIVE
|
2.68
|
2.68
|
94872-9
|
Cholesterol & triglyceride panel
|
-
|
Pt
|
Body fld
|
Qn
| null |
PANEL.CHEM
| 1 |
Cholesterol and triglyceride panel - Body fluid
|
Chol + Trigl Pnl Fld
| null |
ACTIVE
|
2.68
|
2.68
|
94873-7
|
Cortisol.free post corticotropin stimulation panel
|
-
|
Pt
|
Ser/Plas
|
Qn
| null |
PANEL.CHAL
| 1 |
Cortisol.free post corticotropin stimulation panel - Serum or Plasma
|
Cortis F p corticotropin stim Pnl SerPl
| null |
ACTIVE
|
2.68
|
2.68
|
94874-5
|
Cyclic citrullinated peptide Ab.IgG
|
ACnc
|
Pt
|
Ser/Plas
|
Qn
|
IA
|
SERO
| 1 |
Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
|
cCP IgG SerPl IA-aCnc
| null |
ACTIVE
|
2.68
|
2.68
|
94875-2
|
Nuclear Ab.IgG
|
ACnc
|
Pt
|
Ser/Plas
|
Qn
|
IA
|
SERO
| 1 |
Nuclear IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
|
Nuclear IgG SerPl IA-aCnc
| null |
ACTIVE
|
2.68
|
2.68
|
94876-0
|
Self-care priorities for the next 6Mo
|
Find
|
Pt
|
^Patient
|
Nar
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Self-care priorities for the next 6 months [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94877-8
|
Mobility priorities for the next 6Mo
|
Find
|
Pt
|
^Patient
|
Nar
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Mobility priorities for the next 6 months [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94878-6
|
Instrumental activities of daily living priorities for the next 6Mo
|
Find
|
Pt
|
^Patient
|
Nar
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Instrumental activities of daily living priorities for the next 6 months [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94879-4
|
Need for and availability of a cane &or crutch
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of a cane/crutch [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94880-2
|
Need for and availability of a walker
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of a walker [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94881-0
|
Need for and availability of a standard folding walker
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of a standard folding walker [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94882-8
|
Need for and availability of a walker with seat
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of a walker with seat [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94883-6
|
Need for and availability of a walker with wheels
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of a walker with wheels [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94884-4
|
Need for and availability of a wheelchair
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of a wheelchair [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94885-1
|
Need for and availability of a manual wheelchair
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of a manual wheelchair [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94886-9
|
Need for and availability of a motorized wheelchair &or scooter
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of a motorized wheelchair/scooter [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94887-7
|
Need for and availability of a limb prosthesis
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of a limb prosthesis [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94888-5
|
Need for and availability of a specialized seating pad
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of a specialized seating pad [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94889-3
|
Need for and availability of a mechanical lift
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of a mechanical lift [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94890-1
|
Need for and availability of a reacher &or grabber
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of a reacher/grabber [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94891-9
|
Need for and availability of a sock aid
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of a sock aid [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94892-7
|
Need for and availability of an orthotic &or brace
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of an orthotic/brace [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94893-5
|
Need for and availability of a bed rail
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of a bed rail [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94894-3
|
Need for and availability of an electronic bed
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of an electronic bed [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94895-0
|
Need for and availability of grab bars
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of grab bars [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
9489-6
|
Arsenic
|
MCnc
|
Pt
|
Body fld
|
Qn
| null |
DRUG/TOX
| 1 |
Arsenic [Mass/volume] in Body fluid
|
Arsenic Fld-mCnc
| null |
ACTIVE
|
1.0i
|
2.34
|
94896-8
|
Need for and availability of a transfer board
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of a transfer board [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94897-6
|
Need for and availability of a shower &or commode chair
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of a shower/commode chair [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94898-4
|
Need for and availability of a walk or wheel-in shower
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of a walk/wheel-in shower [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
94899-2
|
Need for and availability of glasses or contact lenses
|
Find
|
Pt
|
^Patient
|
Ord
|
CMS Assessment
|
SURVEY.CMS
| 4 |
Need for and availability of glasses or contact lenses [CMS Assessment]
| null | null |
ACTIVE
|
2.68
|
2.68
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.